Statement by Mr. François Hollande, President of the Republic, on the fight against cancer, in Paris on October 31, 2016.

France François Hollande · President of France

31 October 2016 · Opening of the congress against cancer (International Union Against Cancer congress) · Paris, France

Context
Hollande addressed the opening of an international cancer congress in Paris on October 31, 2016, attended by nearly 3,000 representatives from 135 countries and 900 organizations.
Main themes
Fight against cancer, cancer prevention, personalized medicine, France's national cancer plan, genomic medicine, patient support and quality of life, cancer research, tobacco and lifestyle risk factors, screening programs, right to be forgotten for cancer survivors, global cancer statistics, international cooperation against cancer
Duration
~17 min
57th percentile
Words
1,993
57th percentile
Sentences
87
56th percentile
Readability
44
47th percentile
Grade
12.7
53rd percentile
Syntax
3.03
52nd percentile
Vocabulary
2.15
38th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 75%75%
  • Geopolitical 11%11%
  • Ceremonial 8%8%
  • Economic 2%2%
  • Institutional 2%2%
  • Environmental 1%1%
  • Technological 0%0%
  • Not in focus 0%

87 sentences in 26 paragraphs

Ladies and gentlemen ministers,

Mr. President of the International Union Against Cancer,

Madam President of the League Against Cancer,

Ladies and gentlemen,

I wanted to be with you this evening for the opening of your congress because it addresses one of the scourges that the world faces and that affects so many families, so many women, men, and children.

Nearly three thousand of you have come, representing 135 countries and 900 organizations. You are doctors, researchers, public officials, private organizations, but also patients or relatives of patients. Together, you are pooling your experiences to fight against cancer. I thank Jacqueline GODET, the president of the National League Against Cancer, who proposed Paris as the host city because we wanted, after so many years, to be able to host this global congress here in Paris.

I thank President Tezer KUTLUK for choosing our country for this congress. It is true that there is a history - it has been recalled - but there is above all a mobilization that today makes France want to fully engage, not only for its own patients or to prevent the scourge that is cancer but to act in the world. Every year, the figures have been recalled and they are terrible; 8 million people die from cancer. More than 14 million new cases are diagnosed each year, and we already know that by 2025 there will be 19 million simply due to demographic growth. These are the figures.

I do not want to reduce cancer to statistics that would only alarm us because there are also human realities. No country, no population, no generation is spared by cancer, and yet - and this is what must be remembered from this congress - considerable progress has been made. Yesterday, cancers were always fatal. Today, it is increasingly common to be cured, and the challenge is therefore not just to take charge of it medically but to support patients during treatment until recovery, and after recovery.

The way to treat cancer has also evolved considerably with what is called personalized medicine and the development of genetic analysis of tumors. Strategies are therefore becoming increasingly individualized. It is in this perspective that we launched a genomic plan a few days ago that will allow us by 2025 to meet the demands of individualized medicine.

We also know - and this was recalled earlier - that half of cancers could be avoided through preventive actions, and only preventive actions! The stakes are well known: they concern risk behaviors - tobacco, alcohol, diet, exposure to the sun, and so many hazards that are believed to be impossible to control and which correspond, however, to carcinogenic agents found in our environment - and it is in this sense that the fight against pollution and the fight against cancer converge.

To address all these issues - research, treatment evolution, prevention, support for patients and families - France has established a cancer plan since 2003. It brings together all stakeholders. It defines specific objectives and mobilizes specific financial resources. It has become a major presidential project.

It was Jacques CHIRAC who laid the foundations by creating the National Cancer Institute. Then Nicolas SARKOZY consolidated and deepened this policy. In February 2014, I presented the 3rd Cancer Plan around three priorities because I was aware that we needed to evolve. To take into account innovation and research, of course, but also to give full dimension to prevention. This is the case with the National Tobacco Control Program implemented by Marisol TOURAINE. It is never easy; it faces many obstacles, but it was decided with the generalization of the plain packaging. It is also about providing information from school on a number of risk behaviors. Prevention is screening, which has been strengthened with the dissemination of new, simpler tests to use - I am thinking of colorectal cancers - with also specific follow-up established for women for breast cancer, and with new generalized screenings for cervical cancer. Prevention and screening. The first dimension of the cancer plan.

The second priority is to preserve the quality of life of people during and after cancer. I think of the right to be forgotten for former cancer patients: we have finally recognized it - and I believe this can serve as an example for other countries - so that no patient and former patient can be penalized, so that employers can also respect what remission and recovery are, and that employees cannot be discriminated against because they have - or have had - this disease called cancer.

Finally, the third priority of the cancer plan is research. Emphasis has been placed on the resources that must be dedicated to personalized medicine, the one I was talking about, individualized, as well as translational medicine, the one that goes from research to the patient's bedside. And then the dissemination of therapeutic discoveries - I am thinking in particular of what we can do to allow children with cancer to access new treatments in specialized units.

The results of this policy are visible, and in this sense, the congress can allow for the generalization of experiences. Thus, survival times and cure rates for patients in France are among the highest in the world. 60% of cancers are cured; ten years ago, it was 50%. I want to thank the research teams - you know that we are ranked 4th in the world for publications in leading journals in the field of cancer - but also the mobilization of society as a whole, and particularly of associations.

But at the same time, I realize that these results cannot be sufficient and that our vigilance must be permanent in France, in Europe, and in the world. France is therefore participating in international cancer programs: in Europe, it is part of the 19 member nations of the European research program called TRANSCAN. At the global level, we contribute to the Cancer Genome Consortium to ensure that we can analyze all types or subtypes of cancers.

Finally, and this has been said, and I thank here the countries that represent Francophonie, we have a duty with our cooperation policy in Africa to fight against cancer. This is what we have established with the Alliance, the first network for the fight against cancer in Francophone Africa, which includes Cameroon, Côte d'Ivoire, Gabon, Senegal, Madagascar, and many others, and which brings together in this alliance virologists, oncologists, pathologists, and epidemiologists, supported by the WHO.

We know that, as often, it is the poorest who are the most numerous to be victims of scourges - this applies to cancer as well as to other diseases, including even disasters. So we must look at what is happening in Africa - this has been said in relation to AIDS; 600,000 cases of cancer are reported each year, and among those affected, 500,000 die. This is what injustice means: being affected by the disease - more often than elsewhere - and dying from it. Therefore, the challenge - and I thank Mr. SIDIBE for recalling it - is access to care and the most innovative medicines.

For France, this is a global challenge; it is an element of justice, but it is also a claim of human rights, an affirmation of dignity. How can we accept that there are men and women who are treated and others who are not? How can we imagine a world where we know that there are medicines that can cure and populations that will never be able to access them for reasons of price? So France wanted to take an initiative so that we can facilitate the dissemination of innovations, so that we can generalize access to new treatments and improve care. France wanted this issue of treatment costs to be examined at the meeting of the OECD Health Ministers. This will be the first time since 2010 that there will be a meeting at this level to address this issue.

There are many expectations regarding this meeting, and you have just confirmed it. Expectations from patients, expectations from associations, expectations from health actors. You have, Madam President, mentioned the role of women, first because women are the primary victims of cancers; then because women are victims of inequalities in access to prevention, treatment, and screening. Finally, because women are the primary relays of public health policies in all societies of the world, developed or emerging. Therefore, it is evident to place women at the heart of cancer control strategies, and this is what your congress will reaffirm today.

Ladies and gentlemen, I will conclude; there are great battles that can be fought on a global scale. Sometimes, it takes time for them to yield results, resolutions, and agreements. Let us remember the determination that was required and the tenacity that was ours so that in Paris, last December, the climate agreement could be signed. Many did not imagine that we could put all the countries of the world in a position to accept this agreement with specific commitments and with constraints that will weigh on all public choices, which are not, by the way, constraints, but levers for development, with funding that has been released. No one ever thought that once the Paris Agreement was proclaimed, it could be ratified by the end of the year. In Marrakech for COP 22, which will be organized by Morocco, it will not be about looking at what we can do to implement the climate agreement: Marrakech will be the concrete implementation of this agreement since it is now applicable. And when it comes to access to medicines, to the fight against major scourges, and particularly cancer, we can also have the same hope and the same will.

Uniting the world so that it can build a respectful development model: respectful of human rights. This is what you have sought to do for cancer during your congress. Of course, it is the governments, the public institutions that are primarily concerned and that must take their share of responsibility by dedicating the necessary means and financial resources.

But it is also the large organizations - they are represented here, I salute them - it is also the societies themselves because what is at stake is not simply the cost in euros, dollars, or any other currency; it is primarily the years of life lost, the bereaved families, the shortened youth: this is what costs the most and cannot be expressed in money but in lives.

I want to salute all the researchers, all the scientists, all the doctors, all those who contribute to pushing the boundaries of knowledge, who are getting to know the causes of cancers better and treating them. It is the fight, it is true, of medicine since always to develop increasingly precise, adapted, personalized treatments for each patient. It is the fight of society to avoid behaviors that can put us in danger. It is also the fight of a society, of all societies, to bring dignity to patients and to those who are cured.

There you have it, ladies and gentlemen, the meaning of what you are doing here: a great cause, the fight against cancer, great hope as well, great responsibilities. And it is always the same principle: do we want justice, do we want equality, do we want to give rights to every human being wherever they live on whatever continent? There you have it, this question engages the world; it is a question that indeed relates to peace. We face threats - we know them - France has been struck by terrorism like other countries represented here. We know the dangers, but every time we fight against inequalities, every time we advance science, progress, research, every time we give hope to populations, to families to be protected from scourges and for many to be cured, then we triumph over life, we triumph over the values that are ours, we advance humanity.

Thank you.